
Clearside Biomedical CLSD
Quartalsbericht 2025-Q3
hinzugefügt 14.11.2025
Clearside Biomedical P/S 2011-2026 | CLSD
P/S Jährlich Clearside Biomedical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.3 | 46.7 | 3.15 | 19.5 | 62.9 | 1.2 K | 467 | 183 | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.2 K | 3.15 | 249 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Adagene
ADAG
|
35.6 | $ 1.65 | 7.91 % | $ 92.9 M | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.59 | 1.99 % | $ 8.64 B | ||
|
Arrowhead Pharmaceuticals
ARWR
|
7.54 | $ 66.05 | 2.3 % | $ 8.83 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Autolus Therapeutics plc
AUTL
|
1.37 K | $ 1.52 | -16.3 % | $ 388 M | ||
|
Biogen
BIIB
|
2 | $ 184.48 | -1.67 % | $ 26.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 102.17 | 2.32 % | $ 27.2 B | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
AstraZeneca PLC
AZN
|
2.17 | $ 93.52 | -1.2 % | $ 96.9 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 4.25 | 1.67 % | $ 9.25 B | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
5.55 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
1.49 | - | -7.31 % | $ 87 M | ||
|
Bristol-Myers Squibb Company
BMY
|
2.36 | $ 55.71 | -0.28 % | $ 113 B | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 207.49 | 2.22 % | $ 5 B | ||
|
Codiak BioSciences
CDAK
|
10.5 | - | -55.98 % | $ 2.15 M | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Zai Lab Limited
ZLAB
|
85.7 | $ 18.37 | -0.97 % | $ 18.2 B | ||
|
Coherus BioSciences
CHRS
|
0.813 | $ 1.61 | -5.03 % | $ 152 M | ||
|
Catalyst Biosciences
CBIO
|
0.296 | $ 10.84 | 0.46 % | $ 714 M | ||
|
Caladrius Biosciences
CLBS
|
3.58 | - | -16.75 % | $ 25.8 M | ||
|
Celldex Therapeutics
CLDX
|
0.187 | $ 25.59 | -6.54 % | $ 1.65 M | ||
|
Cellectis S.A.
CLLS
|
6.69 | $ 4.22 | -4.2 % | $ 116 M | ||
|
Chimerix
CMRX
|
320 | - | - | $ 756 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
34 | - | -15.15 % | $ 60.3 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
9.7 | $ 37.35 | -0.4 % | $ 3.86 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
4.96 | $ 23.18 | 2.02 % | $ 2.75 B | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Crinetics Pharmaceuticals
CRNX
|
2.6 K | $ 55.11 | 3.49 % | $ 4.45 B | ||
|
CRISPR Therapeutics AG
CRSP
|
89.5 | $ 55.17 | 2.47 % | $ 4.65 B | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.79 | $ 29.43 | 6.09 % | $ 1.43 B |